$1.020
-0.083 (-8.11%)At close
CBAT News
CBAT Events
CBAK Energy Secures $8.22M Order
CBAK Energy Technology reported that a battery pack manufacturer serving the automated guided vehicle market has placed orders totaling approximately $8.22M, including applicable taxes, since their commercial relationship began in 2022. Initial battery cell evaluations took place in 2021. The customer purchases CBAK Energy's 26650 PFS2 and 32140 FS full-tab cylindrical lithium iron phosphate cells for AGV battery packs. AGVs are mobile robots that transport materials in warehouses and manufacturing facilities.
CBAK Energy Reports $4.76M Sales Agreement with European RV Company
CBAK Energy Technology reported approximately $4.76M in cumulative sales to a European recreational vehicle, or RV, energy storage company. The relationship began with cell samples supplied for evaluation in 2023 and expanded into a broader commercial collaboration in 2025. CBAK Energy supplies cylindrical lithium iron phosphate cells and provides engineering support for the customer's RV original equipment manufacturer and aftermarket applications.
CBAK Energy Agrees on Battery Supply Framework with European Tech Company
CBAK Energy Technology announced that it has agreed on a battery supply framework with a European blue-chip technology company serving automotive and industrial markets worldwide. The Company expects orders to be placed in stages under the framework. As of September 27, 2026, cumulative orders from the European Customer had exceeded $4.5M, and CBAK Energy expects the total to continue to grow. The Company expects annual sales from its current business with the European Customer to exceed $30M in each of 2027 and 2028.
CBAK Energy Signs Investment Agreement with Nanjing for 12GWh Capacity
CBAK Energy Technology announced that it has signed an investment agreement with the Nanjing Gaochun Economic Development Zone for the research, development and manufacture of large cylindrical sodium-ion battery cells and integrated battery systems in Nanjing, Jiangsu Province. The project would add 12 gigawatt-hours, GWh, of annual cell production capacity, advancing the Company's previously announced sodium-ion expansion plan. "The 6 GWh expansion would more than double annual cell capacity at our existing Nanjing facility and help us meet strong demand for large cylindrical cells," said Zhiguang Hu, Chief Executive Officer of CBAK Energy. "The 12 GWh investment agreement advances our plans for sodium-ion production. Designing the lines to produce lithium-ion cells as well would give us more options to serve customers as demand develops in both markets."
CBAK Energy Secures $96M Battery Order from Indian Manufacturer
CBAK Energy Technology announced that it has secured a new, large-scale order for battery cells from one of India's two- and three-wheeler manufacturers. With an estimated value of approximately $96M, excluding applicable tax, the order is expected to bring the CBAK Energy manufacturing facility designated for the order to full capacity. The company expects to complete delivery of the order within calendar year 2027. The Indian Customer previously placed smaller-volume orders with CBAK Energy. The new order represents a substantial step-up in volume and marks an expansion in the companies' commercial relationship.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

